agilon health (NYSE:AGL) Trading Up 11.8% - Time to Buy?

agilon health, inc. (NYSE:AGL - Get Free Report)'s stock price was up 11.8% on Monday . The company traded as high as $2.47 and last traded at $2.42. Approximately 1,276,177 shares changed hands during mid-day trading, a decline of 74% from the average daily volume of 4,969,932 shares. The stock had previously closed at $2.16.

Analyst Upgrades and Downgrades

A number of analysts have recently weighed in on AGL shares. Royal Bank of Canada raised their target price on agilon health from $3.00 to $3.50 and gave the company an "outperform" rating in a research note on Wednesday, February 26th. TD Cowen lifted their price objective on agilon health from $3.50 to $6.00 and gave the stock a "hold" rating in a research report on Tuesday, April 15th. Wells Fargo & Company lowered their price objective on agilon health from $6.00 to $5.00 and set an "overweight" rating for the company in a research report on Tuesday, May 13th. Cowen reiterated a "hold" rating on shares of agilon health in a research report on Tuesday, April 15th. Finally, The Goldman Sachs Group lifted their price objective on agilon health from $2.50 to $5.00 and gave the stock a "neutral" rating in a research report on Thursday, May 8th. Two research analysts have rated the stock with a sell rating, eleven have issued a hold rating and five have given a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of "Hold" and an average target price of $4.79.

agilon health Price Performance

The company has a market capitalization of $910.69 million, a price-to-earnings ratio of -2.34 and a beta of 0.14. The company has a 50-day moving average price of $3.42 and a 200-day moving average price of $3.20. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.29 and a current ratio of 1.29.

agilon health (NYSE:AGL - Get Free Report) last posted its earnings results on Tuesday, May 6th. The company reported $0.03 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.01) by $0.04. The company had revenue of $1.53 billion during the quarter, compared to analyst estimates of $1.50 billion. agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. The company's revenue for the quarter was down 4.5% compared to the same quarter last year. During the same period in the previous year, the company earned ($0.02) EPS. On average, equities research analysts expect that agilon health, inc. will post -0.59 EPS for the current fiscal year.

Hedge Funds Weigh In On agilon health

Institutional investors have recently modified their holdings of the business. Ieq Capital LLC bought a new position in shares of agilon health during the 4th quarter valued at about $26,000. Signaturefd LLC lifted its stake in agilon health by 143.0% in the 4th quarter. Signaturefd LLC now owns 14,388 shares of the company's stock valued at $27,000 after acquiring an additional 8,467 shares in the last quarter. Humankind Investments LLC bought a new stake in agilon health in the 4th quarter valued at approximately $30,000. Raymond James Financial Inc. bought a new stake in agilon health in the 4th quarter valued at approximately $33,000. Finally, Cerity Partners LLC bought a new stake in agilon health in the 4th quarter valued at approximately $34,000.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.